Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.

Hoff G, Grotmol T, Skovlund E, Bretthauer M; Norwegian Colorectal Cancer Prevention Study Group.

BMJ. 2009 May 29;338:b1846. doi: 10.1136/bmj.b1846.

2.

Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

Holme Ø, Løberg M, Kalager M, Bretthauer M, Hernán MA, Aas E, Eide TJ, Skovlund E, Schneede J, Tveit KM, Hoff G.

JAMA. 2014 Aug 13;312(6):606-15. doi: 10.1001/jama.2014.8266. Erratum in: JAMA. 2014 Sep 3;312(9):964.

3.

Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention).

Bretthauer M, Gondal G, Larsen K, Carlsen E, Eide TJ, Grotmol T, Skovlund E, Tveit KM, Vatn MH, Hoff G.

Scand J Gastroenterol. 2002 May;37(5):568-73.

PMID:
12059059
4.

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, Andreoni B, Arrigoni A, Bisanti L, Casella C, Crosta C, Falcini F, Ferrero F, Giacomin A, Giuliani O, Santarelli A, Visioli CB, Zanetti R, Atkin WS, Senore C; SCORE Working Group.

J Natl Cancer Inst. 2011 Sep 7;103(17):1310-22. doi: 10.1093/jnci/djr284. Epub 2011 Aug 18. Erratum in: J Natl Cancer Inst. 2011 Dec 21;103(24):1903. Fracchia, M [added].

5.

Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Holme Ø, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G.

Cochrane Database Syst Rev. 2013 Oct 1;9:CD009259. doi: 10.1002/14651858.CD009259.pub2. Review.

PMID:
24085634
6.

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG.

J Natl Cancer Inst. 1993 Aug 18;85(16):1311-8.

PMID:
8340943
7.

Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Jul 6;97(13):989-97.

8.

[Randomized controlled trial of sequence mass screening program for colorectal cancer].

Liu X, Zheng S, Chen K, Ma X, Zhou L, Yu H, Yao K, Chen K, Cai S, Zhang S.

Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Dec;21(6):430-3. Chinese.

PMID:
11860828
9.

Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Atkin WS, Edwards R, Kralj-Hans I, Wooldrage K, Hart AR, Northover JM, Parkin DM, Wardle J, Duffy SW, Cuzick J; UK Flexible Sigmoidoscopy Trial Investigators.

Lancet. 2010 May 8;375(9726):1624-33. doi: 10.1016/S0140-6736(10)60551-X. Epub 2010 Apr 27.

10.

Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.

Lindholm E, Brevinge H, Haglind E.

Br J Surg. 2008 Aug;95(8):1029-36. doi: 10.1002/bjs.6136.

PMID:
18563785
11.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
12.

Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy.

Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD; PLCO Project Team.

N Engl J Med. 2012 Jun 21;366(25):2345-57. doi: 10.1056/NEJMoa1114635. Epub 2012 May 21.

13.

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood.

Mandel JS, Church TR, Ederer F, Bond JH.

J Natl Cancer Inst. 1999 Mar 3;91(5):434-7.

14.
15.

Cluster randomization trial of sequence mass screening for colorectal cancer.

Zheng S, Chen K, Liu X, Ma X, Yu H, Chen K, Yao K, Zhou L, Wang L, Qiu P, Deng Y, Zhang S.

Dis Colon Rectum. 2003 Jan;46(1):51-8.

PMID:
12544522
16.

Evidence for colorectal cancer screening.

Bretthauer M.

Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Review.

PMID:
20833346
18.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk